Cargando…
Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil
The COVID-19 pandemic has created an unprecedented need for epidemiological monitoring using diverse strategies. We conducted a project combining prevalence, seroprevalence, and genomic surveillance approaches to describe the initial pandemic stages in Betim City, Brazil. We collected 3239 subjects...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859412/ https://www.ncbi.nlm.nih.gov/pubmed/35197952 http://dx.doi.org/10.3389/fmicb.2022.799713 |
_version_ | 1784654455881334784 |
---|---|
author | Silva, Ana Valesca Fernandes Gilson Menezes, Diego Moreira, Filipe Romero Rebello Torres, Octávio Alcântara Fonseca, Paula Luize Camargos Moreira, Rennan Garcias Alves, Hugo José Alves, Vivian Ribeiro Amaral, Tânia Maria de Resende Coelho, Adriano Neves Saraiva Duarte, Júlia Maria da Rocha, Augusto Viana de Almeida, Luiz Gonzaga Paula de Araújo, João Locke Ferreira de Oliveira, Hilton Soares de Oliveira, Nova Jersey Cláudio Zolini, Camila de Sousa, Jôsy Hubner de Souza, Elizângela Gonçalves de Souza, Rafael Marques Ferreira, Luciana de Lima Lehmkuhl Gerber, Alexandra Guimarães, Ana Paula de Campos Maia, Paulo Henrique Silva Marim, Fernanda Martins Miguita, Lucyene Monteiro, Cristiane Campos Neto, Tuffi Saliba Pugêdo, Fabrícia Soares Freire Queiroz, Daniel Costa Queiroz, Damares Nigia Alborguetti Cuzzuol Resende-Moreira, Luciana Cunha Santos, Franciele Martins Souza, Erika Fernanda Carlos Voloch, Carolina Moreira Vasconcelos, Ana Tereza de Aguiar, Renato Santana de Souza, Renan Pedra |
author_facet | Silva, Ana Valesca Fernandes Gilson Menezes, Diego Moreira, Filipe Romero Rebello Torres, Octávio Alcântara Fonseca, Paula Luize Camargos Moreira, Rennan Garcias Alves, Hugo José Alves, Vivian Ribeiro Amaral, Tânia Maria de Resende Coelho, Adriano Neves Saraiva Duarte, Júlia Maria da Rocha, Augusto Viana de Almeida, Luiz Gonzaga Paula de Araújo, João Locke Ferreira de Oliveira, Hilton Soares de Oliveira, Nova Jersey Cláudio Zolini, Camila de Sousa, Jôsy Hubner de Souza, Elizângela Gonçalves de Souza, Rafael Marques Ferreira, Luciana de Lima Lehmkuhl Gerber, Alexandra Guimarães, Ana Paula de Campos Maia, Paulo Henrique Silva Marim, Fernanda Martins Miguita, Lucyene Monteiro, Cristiane Campos Neto, Tuffi Saliba Pugêdo, Fabrícia Soares Freire Queiroz, Daniel Costa Queiroz, Damares Nigia Alborguetti Cuzzuol Resende-Moreira, Luciana Cunha Santos, Franciele Martins Souza, Erika Fernanda Carlos Voloch, Carolina Moreira Vasconcelos, Ana Tereza de Aguiar, Renato Santana de Souza, Renan Pedra |
author_sort | Silva, Ana Valesca Fernandes Gilson |
collection | PubMed |
description | The COVID-19 pandemic has created an unprecedented need for epidemiological monitoring using diverse strategies. We conducted a project combining prevalence, seroprevalence, and genomic surveillance approaches to describe the initial pandemic stages in Betim City, Brazil. We collected 3239 subjects in a population-based age-, sex- and neighborhood-stratified, household, prospective; cross-sectional study divided into three surveys 21 days apart sampling the same geographical area. In the first survey, overall prevalence (participants positive in serological or molecular tests) reached 0.46% (90% CI 0.12–0.80%), followed by 2.69% (90% CI 1.88–3.49%) in the second survey and 6.67% (90% CI 5.42–7.92%) in the third. The underreporting reached 11, 19.6, and 20.4 times in each survey. We observed increased odds to test positive in females compared to males (OR 1.88 95% CI 1.25–2.82), while the single best predictor for positivity was ageusia/anosmia (OR 8.12, 95% CI 4.72–13.98). Thirty-five SARS-CoV-2 genomes were sequenced, of which 18 were classified as lineage B.1.1.28, while 17 were B.1.1.33. Multiple independent viral introductions were observed. Integration of multiple epidemiological strategies was able to adequately describe COVID-19 dispersion in the city. Presented results have helped local government authorities to guide pandemic management. |
format | Online Article Text |
id | pubmed-8859412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88594122022-02-22 Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil Silva, Ana Valesca Fernandes Gilson Menezes, Diego Moreira, Filipe Romero Rebello Torres, Octávio Alcântara Fonseca, Paula Luize Camargos Moreira, Rennan Garcias Alves, Hugo José Alves, Vivian Ribeiro Amaral, Tânia Maria de Resende Coelho, Adriano Neves Saraiva Duarte, Júlia Maria da Rocha, Augusto Viana de Almeida, Luiz Gonzaga Paula de Araújo, João Locke Ferreira de Oliveira, Hilton Soares de Oliveira, Nova Jersey Cláudio Zolini, Camila de Sousa, Jôsy Hubner de Souza, Elizângela Gonçalves de Souza, Rafael Marques Ferreira, Luciana de Lima Lehmkuhl Gerber, Alexandra Guimarães, Ana Paula de Campos Maia, Paulo Henrique Silva Marim, Fernanda Martins Miguita, Lucyene Monteiro, Cristiane Campos Neto, Tuffi Saliba Pugêdo, Fabrícia Soares Freire Queiroz, Daniel Costa Queiroz, Damares Nigia Alborguetti Cuzzuol Resende-Moreira, Luciana Cunha Santos, Franciele Martins Souza, Erika Fernanda Carlos Voloch, Carolina Moreira Vasconcelos, Ana Tereza de Aguiar, Renato Santana de Souza, Renan Pedra Front Microbiol Microbiology The COVID-19 pandemic has created an unprecedented need for epidemiological monitoring using diverse strategies. We conducted a project combining prevalence, seroprevalence, and genomic surveillance approaches to describe the initial pandemic stages in Betim City, Brazil. We collected 3239 subjects in a population-based age-, sex- and neighborhood-stratified, household, prospective; cross-sectional study divided into three surveys 21 days apart sampling the same geographical area. In the first survey, overall prevalence (participants positive in serological or molecular tests) reached 0.46% (90% CI 0.12–0.80%), followed by 2.69% (90% CI 1.88–3.49%) in the second survey and 6.67% (90% CI 5.42–7.92%) in the third. The underreporting reached 11, 19.6, and 20.4 times in each survey. We observed increased odds to test positive in females compared to males (OR 1.88 95% CI 1.25–2.82), while the single best predictor for positivity was ageusia/anosmia (OR 8.12, 95% CI 4.72–13.98). Thirty-five SARS-CoV-2 genomes were sequenced, of which 18 were classified as lineage B.1.1.28, while 17 were B.1.1.33. Multiple independent viral introductions were observed. Integration of multiple epidemiological strategies was able to adequately describe COVID-19 dispersion in the city. Presented results have helped local government authorities to guide pandemic management. Frontiers Media S.A. 2022-02-07 /pmc/articles/PMC8859412/ /pubmed/35197952 http://dx.doi.org/10.3389/fmicb.2022.799713 Text en Copyright © 2022 Silva, Menezes, Moreira, Torres, Fonseca, Moreira, Alves, Alves, Amaral, Coelho, Saraiva Duarte, da Rocha, de Almeida, de Araújo, de Oliveira, de Oliveira, Zolini, de Sousa, de Souza, de Souza, Ferreira, Lehmkuhl Gerber, Guimarães, Maia, Marim, Miguita, Monteiro, Neto, Pugêdo, Queiroz, Queiroz, Resende-Moreira, Santos, Souza, Voloch, Vasconcelos, de Aguiar and Souza. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Silva, Ana Valesca Fernandes Gilson Menezes, Diego Moreira, Filipe Romero Rebello Torres, Octávio Alcântara Fonseca, Paula Luize Camargos Moreira, Rennan Garcias Alves, Hugo José Alves, Vivian Ribeiro Amaral, Tânia Maria de Resende Coelho, Adriano Neves Saraiva Duarte, Júlia Maria da Rocha, Augusto Viana de Almeida, Luiz Gonzaga Paula de Araújo, João Locke Ferreira de Oliveira, Hilton Soares de Oliveira, Nova Jersey Cláudio Zolini, Camila de Sousa, Jôsy Hubner de Souza, Elizângela Gonçalves de Souza, Rafael Marques Ferreira, Luciana de Lima Lehmkuhl Gerber, Alexandra Guimarães, Ana Paula de Campos Maia, Paulo Henrique Silva Marim, Fernanda Martins Miguita, Lucyene Monteiro, Cristiane Campos Neto, Tuffi Saliba Pugêdo, Fabrícia Soares Freire Queiroz, Daniel Costa Queiroz, Damares Nigia Alborguetti Cuzzuol Resende-Moreira, Luciana Cunha Santos, Franciele Martins Souza, Erika Fernanda Carlos Voloch, Carolina Moreira Vasconcelos, Ana Tereza de Aguiar, Renato Santana de Souza, Renan Pedra Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil |
title | Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil |
title_full | Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil |
title_fullStr | Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil |
title_full_unstemmed | Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil |
title_short | Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil |
title_sort | seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the sars-cov-2 pandemic in betim, brazil |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859412/ https://www.ncbi.nlm.nih.gov/pubmed/35197952 http://dx.doi.org/10.3389/fmicb.2022.799713 |
work_keys_str_mv | AT silvaanavalescafernandesgilson seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT menezesdiego seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT moreirafiliperomerorebello seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT torresoctavioalcantara seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT fonsecapaulaluizecamargos seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT moreirarennangarcias seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT alveshugojose seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT alvesvivianribeiro seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT amaraltaniamariaderesende seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT coelhoadrianoneves seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT saraivaduartejuliamaria seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT darochaaugustoviana seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT dealmeidaluizgonzagapaula seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT dearaujojoaolockeferreira seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT deoliveirahiltonsoares seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT deoliveiranovajerseyclaudio seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT zolinicamila seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT desousajosyhubner seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT desouzaelizangelagoncalves seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT desouzarafaelmarques seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT ferreiralucianadelima seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT lehmkuhlgerberalexandra seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT guimaraesanapauladecampos seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT maiapaulohenriquesilva seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT marimfernandamartins seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT miguitalucyene seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT monteirocristianecampos seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT netotuffisaliba seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT pugedofabriciasoaresfreire seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT queirozdanielcosta seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT queirozdamaresnigiaalborguetticuzzuol seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT resendemoreiralucianacunha seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT santosfrancielemartins seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT souzaerikafernandacarlos seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT volochcarolinamoreira seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT vasconcelosanatereza seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT deaguiarrenatosantana seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil AT desouzarenanpedra seroprevalenceprevalenceandgenomicsurveillancemonitoringtheinitialphasesofthesarscov2pandemicinbetimbrazil |